Elixirgen Scientific

Elixirgen Scientific provides advanced tools and services based on human induced pluripotent stem cell (iPSC) technology to accelerate drug discovery, disease modeling, and regenerative medicine research. Their proprietary Quick-Tissue™ platform enables rapid differentiation of iPSCs/ESCs into diverse functional human cell types within days. The company offers off-the-shelf kits, custom differentiation services, novel assay solutions—including patient-specific panels like their Alzheimer's Disease Panel—and operates a cGMP-compliant facility in Japan for contract manufacturing of investigational mRNA drugs. They have achieved ISO9001 certification reflecting high quality standards. Their offerings are widely used by academic labs and pharmaceutical companies globally to model diseases such as Alzheimer’s or Rett syndrome with physiologically relevant human cells—enabling more predictive preclinical studies while reducing time/costs compared to traditional methods.